CN117222402A - 新制剂 - Google Patents

新制剂 Download PDF

Info

Publication number
CN117222402A
CN117222402A CN202280031387.XA CN202280031387A CN117222402A CN 117222402 A CN117222402 A CN 117222402A CN 202280031387 A CN202280031387 A CN 202280031387A CN 117222402 A CN117222402 A CN 117222402A
Authority
CN
China
Prior art keywords
formulation
mol
content
relative
total weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280031387.XA
Other languages
English (en)
Chinese (zh)
Inventor
M·费兰德
S·勒拉梅
E·雷伊
L·桑塔
M·阿巴西
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Matheson Ag
Original Assignee
Matheson Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matheson Ag filed Critical Matheson Ag
Publication of CN117222402A publication Critical patent/CN117222402A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN202280031387.XA 2021-04-30 2022-04-29 新制剂 Pending CN117222402A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21305559 2021-04-30
EP21305559.3 2021-04-30
PCT/EP2022/061511 WO2022229402A1 (en) 2021-04-30 2022-04-29 New formulation

Publications (1)

Publication Number Publication Date
CN117222402A true CN117222402A (zh) 2023-12-12

Family

ID=75904839

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280031387.XA Pending CN117222402A (zh) 2021-04-30 2022-04-29 新制剂

Country Status (9)

Country Link
US (1) US20240325294A1 (https=)
EP (1) EP4329727A1 (https=)
JP (1) JP2024516264A (https=)
KR (1) KR20240006032A (https=)
CN (1) CN117222402A (https=)
AU (1) AU2022264844A1 (https=)
CA (1) CA3217538A1 (https=)
MX (1) MX2023012801A (https=)
WO (1) WO2022229402A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026013080A1 (en) 2024-07-08 2026-01-15 InnoCore Technologies Holding B.V. Pharmaceutical composition based on biodegradable polymers comprising polyoxazoline

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2741628B1 (fr) 1995-11-29 1998-02-06 Centre Nat Rech Scient Nouveaux hydrogels a base de copolymeres trisequences et leur application notamment a la liberation progressive de principes actifs
US9023897B2 (en) * 2010-12-29 2015-05-05 Medincell Biodegradable drug delivery compositions
CN103446043B (zh) * 2012-05-29 2015-06-17 辽宁省计划生育科学研究院 一种原位凝胶注射植入剂
EP2866837B1 (en) * 2012-06-27 2022-12-14 Medincell S.A. Biodegradable drug delivery for hydrophobic compositions
US10188602B2 (en) * 2016-09-29 2019-01-29 Gesea Biosciences Inc. Bioerodible implant for long-term drug delivery and associated methods of manufacture and use
EP3655017B1 (en) * 2017-07-17 2025-01-22 Medincell S.A. Pharmaceutical composition
KR102441064B1 (ko) * 2017-07-17 2022-09-06 현대자동차주식회사 연료전지 차량의 제어 방법

Also Published As

Publication number Publication date
MX2023012801A (es) 2023-11-08
JP2024516264A (ja) 2024-04-12
WO2022229402A1 (en) 2022-11-03
AU2022264844A1 (en) 2023-11-23
EP4329727A1 (en) 2024-03-06
US20240325294A1 (en) 2024-10-03
CA3217538A1 (en) 2022-11-03
KR20240006032A (ko) 2024-01-12

Similar Documents

Publication Publication Date Title
US9364544B2 (en) Pharmaceutical compositions containing functionalized triblock copolymers
KR102745079B1 (ko) 약제학적 조성물
MX2014015902A (es) Suministro de farmaco biodegradable para las composiciones hidrofobicas.
US20140271767A1 (en) Biocompatible hydrogel polymer matrix for delivery of cells
US20210169778A1 (en) Injectable composition with aromatase inhibitor
EP2691079A2 (en) Biodegradable compositions suitable for controlled release
Sandker et al. Degradation, intra-articular retention and biocompatibility of monospheres composed of [PDLLA-PEG-PDLLA]-b-PLLA multi-block copolymers
KR20040021760A (ko) 약물 담지능력이 우수한 블록 공중합체 미셀 조성물
CN117222402A (zh) 新制剂
US8084427B2 (en) Subcutaneous implants containing a degradation-resistant polylactide polymer
CN113730339A (zh) 一种黄体酮缓释组合物及其应用
Park et al. Injectable and sustained delivery of human growth hormone using chemically modified Pluronic copolymer hydrogels
US20260069531A1 (en) Polymeric leuprolide acetate formulations
CN116262099B (zh) 一种缓释温敏凝胶及其制备方法和其应用
JP2026502795A (ja) 溶媒除去技術に基づく無菌ｉｎ－ｓｉｔｕゲルの製造方法及びその製品
WO2025255203A1 (en) Compositions and methods for treating ocular diseases
Pharm Fahad Pervaiz
BR122024013431A2 (pt) Método de produção de um hidrogel, hidrogel, e, invenção
Chen Novel delivery systems for hormones

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination